 |
市場調査レポート
商品コード
1301048
メタゲノミクスの市場規模、シェア、動向分析レポート：技術別（ショットガンシーケンス、16Sシーケンス、全ゲノムシーケンス）、製品別、ワークフロー別、アプリケーション別、地域別、およびセグメント予測：2023年～2030年Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, By Region, And Segment Forecasts, 2023 - 2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| メタゲノミクスの市場規模、シェア、動向分析レポート：技術別（ショットガンシーケンス、16Sシーケンス、全ゲノムシーケンス）、製品別、ワークフロー別、アプリケーション別、地域別、およびセグメント予測：2023年～2030年 |
|
出版日: 2023年06月15日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
メタゲノミクス市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界のメタゲノミクス市場規模は2030年までに40億2,000万米ドルに達する見込みです。
2023年から2030年までのCAGRは14.8%で市場は拡大すると予測されています。ゲノミクスとプロテオミクスの研究の増加、個別化医薬品の採用の増加、生物学的製剤への要求の高まりがシーケンサーの需要を促進しており、業界の成長を後押ししています。例えば、2022年8月、Illumina, Inc.は、ソリューションセンターを開発することにより、ブラジルでゲノミクス事業を拡大する計画を発表しました。新施設の設立は、臨床ゲノミクスに対する需要の高まりとラテンアメリカにおける同社の足跡を加速する結果です。
各社による研究開発投資の活発化は、多くのアプリケーションにおけるメタゲノミクスの利用に大きな影響を与えると推定されます。例えば、2021年4月、Agilent Technologies, Inc.は、NGSベースの精密腫瘍学ソリューション開発企業であるResolution Bioscience, Inc.を買収しました。レゾリューション・バイオサイエンスの非侵襲的リキッドバイオプシー・プラットフォームとアジレントの組織ベースのコンパニオン診断薬の組み合わせは、プレシジョン・オンコロジー向けNGSテクノロジーにおけるアジレントの市場ポジションを拡大すると予想されます。
メタゲノミクスが環境用途に多く採用されているもう一つの要因は、微生物が生物地球化学サイクルに直接関与していることです。微生物による石油炭化水素などの炭素源の分解は、研究者にバイオ燃料生産のためのメタゲノミクスプロセスの研究を促しています。さらに、非培養微生物に未発見の生体分子が多数存在することから、農業、食品安全、化学、工業、その他の関連用途へのメタゲノミクスの導入が加速しました。
COVID-19の発生以来、ライフサイエンスおよびバイオテクノロジー業界の主要利害関係者は、COVID-19の追跡、検出、治療のためのソリューションを求めています。メタゲノミクス解析は、ウイルスの検出と追跡において重要な役割を果たしています。感染の効果的な診断のために、様々なシーケンス監視プラットフォームとソリューションが展開されています。例えば、2021年5月、オックスフォード大学とオラクルは、コロナウイルス感染リスクを軽減するための堅牢なクラウドベースのゲノムシーケンスおよび解析プラットフォームを開発するための戦略的パートナーシップを発表しました。
さらに、NGSプラットフォームを使用する学術機関の研究を促進するために政府から提供される資金は、メタゲノミクスツールの利用をさらに増加させる。例えば、2021年2月、カナダ政府はCOVID-19の診断のための多層的アプローチを実施するために5,300万米ドルを投資しました。カナダ政府は、ゲノム配列決定と解析技術を活用して、望ましい結果を達成する予定です。
メタゲノミクスによって生成されるデータの質も、解析コストを増大させる要因のひとつです。データの質は、塩基配列決定プロセスにおける平均実行回数に大きく依存します。高品質の解析にはコストがかかります。しかし、RNA-Seqのような新しい技術の採用は、精度と迅速な結果、そして価格の低下により急速に増加しています。シーケンシングのコストは毎年5～10倍に、計算能力は2年ごとに2倍になることが確認されています。
メタゲノミクス市場レポートハイライト
- 製品別では、キット＆試薬セグメントが最大の市場シェアを占める。これらの製品に対する数量ベースの需要は高いです。キットおよび試薬の市場浸透率の高さが、さらに収益シェアの高さに寄与しています。
- 技術別では、ショットガンシーケンスセグメントが予測期間中最も速いCAGRで最大のシェアを占めると予測されます。サンプル中の全ゲノムDNAを読み取る能力などの利点がこの技術に競争優位性を与え、研究者の間でショットガンシーケンスの採用が拡大しています。
- アプリケーション別では、臨床診断分野が予測期間を通じてCAGRが最も速いと予測されます。シーケンシング技術を用いた個別化治療の開発に向けた研究イニシアティブが臨床研究分野の成長に影響を与え、成長を促進すると予想されるため。
- ワークフロー別では、シーケンシングセグメントが2022年に最大のシェアを占めました。これは、容易なワークフローモデルの採用、迅速な結果に対する需要、シーケンシング＆データ解析サービスの需要を促進するシステムの価格と比較してサンプルあたりの解析コストが低いこと別。
- 北米は、ゲノム研究に注力する大手企業や大規模な研究・学術機関の確立されたマーケティング・流通網の存在により、2022年に世界のメタゲノミクス業界を支配しました。
- 主要企業としては、Illumina.Inc.、Thermo Fisher Scientific, Inc.、QIAGEN、Promega Corporationなどです。
目次
第1章 調査手法と範囲
- 市場セグメンテーションと範囲
- 市場の定義
- 情報分析
- 市場形成とデータの可視化
- データの検証と公開
- 調査の仮定
- 情報調達
- 1次調査
- 情報またはデータ分析
- 市場の形成と検証
- 市場モデル
- 世界市場：CAGRの計算
- 目的
第2章 エグゼクティブサマリー
- 市場スナップショット
- セグメントのスナップショット
- 競合情勢のスナップショット
第3章 市場変数、動向、および範囲
- 市場系統の見通し
- 親市場の見通し
- 関連/補助的な市場見通し
- 市場動向と展望
- 市場力学
- シーケンス費用の減少
- バイオテクノロジーとバイオインフォマティクス技術の発展
- さまざまな研究のための微生物スクリーニングへの関心の高まり
- メタゲノミクスを補完するゲノミクスの新分野の出現
- 市場抑制要因分析
- 計算やさまざまな分析ツールへのアクセスが制限されている
- メタゲノミクスの総コストが高い
- 事業環境分析
- SWOT分析;要因別（政治・法律、経済・技術）
- ポーターのファイブフォース分析
- 新型コロナウイルス感染症（COVID-19）の影響分析
第4章 テクノロジービジネス分析
- メタゲノミクス市場：技術変動分析
- ショットガンのシーケンス
- ショットガンシーケンシング市場、2018～2030年（100万米ドル）
- 16Sシーケンス
- 16Sシーケンス市場、2018～2030年（100万米ドル）
- 全ゲノムシーケンス決定
- 全ゲノムシーケンス市場、2018年～2030年（100万米ドル）
- その他
- その他市場、2018-2030（100万米ドル）
第5章 製品ビジネス分析
- メタゲノミクス市場：製品変動分析
- キットと試薬
- キットおよび試薬市場、2018-2030（100万米ドル）
- シーケンスおよびデータ分析サービス
- シーケンシングおよびデータ分析サービス市場、2018年～2030年（100万米ドル）
- ソフトウェア
- ソフトウェア市場、2018-2030（100万米ドル）
第6章 アプリケーションビジネス分析
- メタゲノミクス市場：アプリケーションの変動分析
- 環境への応用
- 環境アプリケーション市場、2018～2030年（100万米ドル）
- 臨床診断アプリケーション
- 臨床診断アプリケーション市場、2018年～2030年（100万米ドル）
- 創薬アプリケーション
- 創薬アプリケーション市場、2018年～2030年（100万米ドル）
- バイオテクノロジーの応用
- バイオテクノロジー応用市場、2018年～2030年（100万米ドル）
- 食品および栄養アプリケーション
- 食品および栄養アプリケーション市場、2018-2030（100万米ドル）
- その他
- その他市場、2018-2030（100万米ドル）
第7章 ワークフロービジネス分析
- メタゲノミクス市場：ワークフロー変動分析
- プリシーケンス
- プレシーケンス市場、2018～2030年（100万米ドル）
- シーケンス
- シーケンシング市場、2018～2030年（100万米ドル）
- データ分析
- データ分析市場、2018-2030（100万米ドル）
第8章 地域ビジネス分析
- 地域別メタゲノミクス市場シェア、2022年および2030年
- 北米
- SWOT分析
- 北米のメタゲノミクス市場、2018年～2030年（100万米ドル）
- 米国
- カナダ
- 欧州
- SWOT分析
- 欧州のメタゲノミクス市場、2018年～2030年（100万米ドル）
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
- アジア太平洋地域
- SWOT分析
- アジア太平洋のメタゲノミクス市場、2018年～2030年（100万米ドル）
- 日本
- 中国
- インド
- 韓国
- オーストラリア
- タイ
- ラテンアメリカ
- SWOT分析
- ラテンアメリカのメタゲノミクス市場、2018年～2030年（100万米ドル）
- ブラジル
- メキシコ
- アルゼンチン
- MEA
- SWOT分析
- MEAのメタゲノミクス市場、2018年～2030年（100万米ドル）
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート
第9章 競合情勢
- 会社の分類
- 戦略マッピング
- 企業プロファイル・一覧表
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc..
- PerkinElmer, Inc.
- Promega Corporation
- Oxford Nanopore Technologies
- Qiagen
- Takara Bio, Inc.
- Novogene Co., Ltd.
- F. Hoffmann-La Roche Ltd.
図表
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 Global Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 4 Global Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 5 Global Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 6 Global Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 7 Global Metagenomics Market, by Region, 2018 - 2030 (USD Million)
- Table 8 North America Metagenomics Market, by Country, 2018 - 2030 (USD Million)
- Table 9 North America Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 10 North America Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 11 North America Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 12 North America Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 13 U.S. Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 14 U.S. Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 15 U.S. Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 16 U.S. Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 17 Canada Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 18 Canada Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 19 Canada Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 20 Canada Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 21 Europe Metagenomics Market, by Country, 2018 - 2030 (USD Million)
- Table 22 Europe Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 23 Europe Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 24 Europe Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 25 Europe Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 26 Germany Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 27 Germany Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 28 Germany Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 29 Germany Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 30 UK Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 31 UK Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 32 UK Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 33 UK Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 34 France Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 35 France Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 36 France Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 37 France Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 38 Italy Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 39 Italy Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 40 Italy Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 41 Italy Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 42 Spain Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 43 Spain Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 44 Spain Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 45 Spain Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 46 Denmark Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 47 Denmark Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 48 Denmark Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 49 Denmark Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 50 Norway Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 51 Norway Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 52 Norway Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 53 Norway Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 54 Sweden Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 55 Sweden Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 56 Sweden Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 57 Sweden Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 58 Asia Pacific Metagenomics Market, by Country, 2018 - 2030 (USD Million)
- Table 59 Asia Pacific Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 60 Asia Pacific Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 61 Asia Pacific Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 62 Asia Pacific Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 63 China Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 64 China Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 65 China Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 66 China Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 67 Japan Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 68 Japan Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 69 Japan Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 70 Japan Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 71 India Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 72 India Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 73 India Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 74 India Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 75 South Korea Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 76 South Korea Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 77 South Korea Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 78 South Korea Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 79 Australia Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 80 Australia Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 81 Australia Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 82 Australia Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 83 Latin America Metagenomics Market, by Country, 2018 - 2030 (USD Million)
- Table 84 Thailand Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 85 Thailand Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 86 Thailand Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 87 Thailand Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 88 Latin America Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 89 Latin America Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 90 Latin America Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 91 Latin America Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 92 Brazil Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 93 Brazil Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 94 Brazil Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 95 Brazil Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 96 Mexico Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 97 Mexico Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 98 Mexico Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 99 Mexico Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 100 Argentina Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 101 Argentina Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 102 Argentina Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 103 Argentina Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 104 Middle East & Africa Metagenomics Market, by Country, 2018 - 2030 (USD Million)
- Table 105 Middle East & Africa Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 106 Middle East & Africa Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 107 Middle East & Africa Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 108 Middle East & Africa Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 109 South Africa Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 110 South Africa Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 111 South Africa Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 112 South Africa Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 113 Saudi Arabia Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 114 Saudi Arabia Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 115 Saudi Arabia Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 116 Saudi Arabia Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 117 UAE Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 118 UAE Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 119 UAE Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 120 UAE Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
- Table 121 Kuwait Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
- Table 122 Kuwait Metagenomics Market, by Product, 2018 - 2030 (USD Million)
- Table 123 Kuwait Metagenomics Market, by Application, 2018 - 2030 (USD Million)
- Table 124 Kuwait Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information Procurement
- Fig. 3 Primary Research Pattern
- Fig. 4 Market Research Approaches
- Fig. 5 Value Chain - Based Sizing & Forecasting
- Fig. 6 Market Formulation & Validation
- Fig. 7 Metagenomics, Market Segmentation
- Fig. 8 Market Snapshot, 2021
- Fig. 9 Market Trends & Outlook
- Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
- Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
- Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
- Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- Fig. 14 Porter's Five Forces Analysis
- Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
- Fig. 16 Global Metagenomics Market: Technology Movement Analysis
- Fig. 17 Global Metagenomics Market, for Shotgun Sequencing, 2018 - 2030 (USD Million)
- Fig. 18 Global Metagenomics Market, for 16S Sequencing, 2018 - 2030 (USD Million)
- Fig. 19 Global Metagenomics Market, for Whole Genome Sequencing, 2018 - 2030 (USD Million)
- Fig. 20 Global Metagenomics Market, for Others, 2018 - 2030 (USD Million)
- Fig. 21 Global Metagenomics Market: Product Movement Analysis
- Fig. 22 Global Metagenomics Market, for Kits & Reagents, 2018 - 2030 (USD Million)
- Fig. 23 Global Metagenomics Market, for Sequencing & Data Analytics Services, 2018 - 2030 (USD Million)
- Fig. 24 Global Metagenomics Market, for Software, 2018 - 2030 (USD Million)
- Fig. 25 Global Metagenomics Market: Application Movement Analysis
- Fig. 26 Global Metagenomics Market, for Environmental, 2018 - 2030 (USD Million)
- Fig. 27 Global Metagenomics Market, for Clinical Diagnostics, 2018 - 2030 (USD Million)
- Fig. 28 Global Metagenomics Market, for Drug Discovery, 2018 - 2030 (USD Million)
- Fig. 29 Global Metagenomics Market, for Biotechnology, 2018 - 2030 (USD Million)
- Fig. 30 Global Metagenomics Market, for Food & Nutrition, 2018 - 2030 (USD Million)
- Fig. 31 Global Metagenomics Market, for Others, 2018 - 2030 (USD Million)
- Fig. 32 Global Metagenomics Market: Workflow Movement Analysis
- Fig. 33 Global Metagenomics Market, for Pre - sequencing, 2018 - 2030 (USD Million)
- Fig. 34 Global Metagenomics Market, for Sequencing, 2018 - 2030 (USD Million)
- Fig. 35 Global Metagenomics Market, for Data Analysis, 2018 - 2030 (USD Million)
- Fig. 36 Regional Marketplace: Key Takeaways
- Fig. 37 Regional Outlook, 2021 & 2030
- Fig. 38 Global Metagenomics Market: Region Movement Analysis
- Fig. 39 North America Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 40 U.S. Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 41 Canada Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 42 Europe Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 43 Germany Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 44 UK Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 45 France Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 46 Italy Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 47 Spain Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 48 Denmark Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 49 Norway Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 50 Sweden Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 51 Asia Pacific Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 52 Japan Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 53 China Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 54 India Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 55 Thailand Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 56 Australia Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 57 South Korea Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 58 Latin America Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 59 Brazil Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 60 Mexico Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 61 Argentina Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 62 Middle East and Africa Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 63 South Africa Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 64 Saudi Arabia Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 65 UAE Metagenomics Market, 2018 - 2030 (USD Million)
- Fig. 66 Kuwait Metagenomics Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-452-9
Metagenomics Market Growth & Trends
The global metagenomics market size is expected to reach USD 4.02 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.8% from 2023 to 2030. The increasing research in genomics and proteomics, the rising adoption of personalized medicines, and escalating requirement for biologic products are driving the demand for sequencing, fueling the growth of the industry. For instance, in August 2022, Illumina, Inc. announced its plans to expand genomics operations in Brazil by developing a solution center. The establishment of the new facility is the result of rising demand for clinical genomics and accelerating the company's footprint in Latin America.
A boost in R&D investments by the players is estimated to have a considerable impact on the usage of metagenomics in numerous applications. For instance, in April 2021, Agilent Technologies, Inc. acquired Resolution Bioscience, Inc., an NGS-based precision oncology solution developing company. The combination of Resolution Bioscience's noninvasive liquid biopsy platform with Agilent's tissue-based companion diagnostics is anticipated to expand Agilent's market position in NGS technologies for precision oncology.
Another factor contributing to the high adoption of metagenomics for environmental use is the direct involvement of microorganisms in the biogeochemical cycle. The degradation of carbon sources such as petroleum hydrocarbons by microbes has encouraged researchers to study metagenomics processes for the production of biofuels. In addition, the presence of a large number of undiscovered biomolecules in non-cultured microorganisms accelerated the adoption of metagenomics in agriculture, food safety, chemical, industrial, and other related applications.
Since the outbreak of COVID-19, key stakeholders in the life sciences and biotechnology industry are seeking solutions for COVID-19 tracking, detection, and treatment. Metagenomics analysis plays a crucial role in the detection and tracing of the virus. Various sequencing surveillance platforms and solutions are being deployed for effective diagnosis of infection. For instance, in May 2021, Oxford University and Oracle announced a strategic partnership to develop robust cloud-based genomic sequencing and analysis platform to mitigate the risk of coronavirus infection.
Moreover, funds provided by the government for promoting research in academic institutes, which use NGS platforms, further increase the usage of metagenomics tools. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach for the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.
The quality of data generated through metagenomics is another factor that increases the cost of analysis. The quality of data is highly dependent on the average number of times the bases are run during the sequencing process. The high-quality analysis is expensive. However, the adoption of emerging novel techniques, such as RNA-Seq, is rapidly increasing owing to accuracy and rapid results along with a decline in prices. It is observed that the cost of sequencing falls 5 to 10 times every year and the value of computing power doubles every two years.
Metagenomics Market Report Highlights
- By product, the kits & reagents segment accounts for the largest market share. The demand in terms of volumes is high for these products. High market penetration of kits and reagents further contributes toward their highest revenue share
- By technology, the shotgun sequencing segment is estimated to have the largest share with the fastest CAGR over the forecast period. The advantages such as the ability to read all genomic DNA in a sample give a competitive edge to the technology resulting in the growing adoption of shotgun sequencing among researchers
- By application, the clinical diagnostics segment is anticipated to have the fastest CAGR throughout the forecast period. Owing to the research initiatives for the development of personalized therapies using sequencing technology are expected to impact growth in the area of clinical research, hence, propelling the growth
- By workflow, the sequencing segment held the largest share in 2022, owing to the adoption of easy workflow models, demand for rapid results, and lower cost of per sample analysis compared to the price of systems driving the demand for sequencing & data analytics services
- North America dominated the global metagenomics industry in 2022 owing to the presence of well-established marketing and distribution network of major companies and large-sized research & academic institutes, which focus on genomic studies
- A few of the key players include Illumina. Inc.; Thermo Fisher Scientific, Inc.; QIAGEN; and Promega Corporation
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Information analysis
- 1.2.2. Market formulation & data visualization
- 1.2.3. Data validation & publishing
- 1.3. Research Assumptions
- 1.4. Information Procurement
- 1.4.1. Primary Research
- 1.5. Information or Data Analysis
- 1.6. Market Formulation & Validation
- 1.7. Market Model
- 1.8. Global Market: CAGR Calculation
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Declining expenses of sequencing
- 3.3.2. Developments in biotechnology & bioinformatics techniques
- 3.3.3. Rising interest in microbial screening for different investigations
- 3.3.4. Emergence of new fields in genomics that complement metagenomics
- 3.4. Market Restraint Analysis
- 3.4.1. Limited accessibility to computation and different analytic tools
- 3.4.2. High overall cost of metagenomics
- 3.5. Business Environment Analysis
- 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
- 3.5.2. Porter's Five Forces Analysis
- 3.6. COVID - 19 Impact Analysis
Chapter 4. Technology Business Analysis
- 4.1. Metagenomics market: Technology Movement Analysis
- 4.2. Shotgun Sequencing
- 4.2.1. Shotgun Sequencing Market, 2018 - 2030 (USD Million)
- 4.3. 16S Sequencing
- 4.3.1. 16S Sequencing Market, 2018 - 2030 (USD Million)
- 4.4. Whole Genome Sequencing
- 4.4.1. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 4.5. Others
- 4.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Product Business Analysis
- 5.1. Metagenomics market: Product Movement Analysis
- 5.2. Kits and Reagents
- 5.2.1. Kits and Reagents Market, 2018 - 2030 (USD Million)
- 5.3. Sequencing & Data Analytics Services
- 5.3.1. Sequencing & Data Analytics Services Market, 2018 - 2030 (USD Million)
- 5.4. Software
- 5.4.1. Software Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
- 6.1. Metagenomics market: Application Movement Analysis
- 6.2. Environmental Application
- 6.2.1. Environmental Application Market, 2018 - 2030 (USD Million)
- 6.3. Clinical Diagnostics Applications
- 6.3.1. Clinical Diagnostics Applications Market, 2018 - 2030 (USD Million)
- 6.4. Drug Discovery Applications
- 6.4.1. Drug Discovery Applications Market, 2018 - 2030 (USD Million)
- 6.5. Biotechnology Applications
- 6.5.1. Biotechnology Applications Market, 2018 - 2030 (USD Million)
- 6.6. Food & Nutrition Applications
- 6.6.1. Food & Nutrition Applications Market, 2018 - 2030 (USD Million)
- 6.7. Others
- 6.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Workflow Business Analysis
- 7.1. Metagenomics market: Workflow Movement Analysis
- 7.2. Pre - sequencing
- 7.2.1. Pre - sequencing Market, 2018 - 2030 (USD Million)
- 7.3. Sequencing
- 7.3.1. Sequencing Market, 2018 - 2030 (USD Million)
- 7.4. Data Analysis
- 7.4.1. Data Analysis Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
- 8.1. Metagenomics market Share By Region, 2022 & 2030
- 8.2. North America
- 8.2.1. SWOT Analysis
- 8.2.2. North America Metagenomics market, 2018 - 2030 (USD Million)
- 8.2.3. U.S.
- 8.2.3.1. Key Country Dynamics
- 8.2.3.2. Competitive Scenario
- 8.2.3.3. Regulatory Framework
- 8.2.3.4. Target Disease Prevalence
- 8.2.3.5. U.S. Metagenomics market, 2018 - 2030 (USD Million)
- 8.2.4. Canada
- 8.2.4.1. Key Country Dynamics
- 8.2.4.2. Competitive Scenario
- 8.2.4.3. Regulatory Framework
- 8.2.4.4. Target Disease Prevalence
- 8.2.4.5. Canada Metagenomics market, 2018 - 2030 (USD Million)
- 8.3. Europe
- 8.3.1. SWOT Analysis
- 8.3.2. Europe Metagenomics market, 2018 - 2030 (USD Million)
- 8.3.3. Germany
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Target Disease Prevalence
- 8.3.3.5. Germany Metagenomics market, 2018 - 2030 (USD Million)
- 8.3.4. UK
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. Target Disease Prevalence
- 8.3.4.5. UK Metagenomics market, 2018 - 2030 (USD Million)
- 8.3.5. France
- 8.3.5.1. Key Country Dynamics
- 8.3.5.2. Competitive Scenario
- 8.3.5.3. Regulatory Framework
- 8.3.5.4. Target Disease Prevalence
- 8.3.5.5. France Metagenomics market, 2018 - 2030 (USD Million)
- 8.3.6. Italy
- 8.3.6.1. Key Country Dynamics
- 8.3.6.2. Competitive Scenario
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Target Disease Prevalence
- 8.3.6.5. Italy Metagenomics market, 2018 - 2030 (USD Million)
- 8.3.7. Spain
- 8.3.7.1. Key Country Dynamics
- 8.3.7.2. Competitive Scenario
- 8.3.7.3. Regulatory Framework
- 8.3.7.4. Target Disease Prevalence
- 8.3.7.5. Spain Metagenomics market, 2018 - 2030 (USD Million)
- 8.3.8. Denmark
- 8.3.8.1. Key Country Dynamics
- 8.3.8.2. Competitive Scenario
- 8.3.8.3. Regulatory Framework
- 8.3.8.4. Target Disease Prevalence
- 8.3.8.5. Denmark Metagenomics market, 2018 - 2030 (USD Million)
- 8.3.9. Sweden
- 8.3.9.1. Key Country Dynamics
- 8.3.9.2. Competitive Scenario
- 8.3.9.3. Regulatory Framework
- 8.3.9.4. Target Disease Prevalence
- 8.3.9.5. Sweden Metagenomics market, 2018 - 2030 (USD Million)
- 8.3.10. Norway
- 8.3.10.1. Key Country Dynamics
- 8.3.10.2. Competitive Scenario
- 8.3.10.3. Regulatory Framework
- 8.3.10.4. Target Disease Prevalence
- 8.3.10.5. Norway Metagenomics market, 2018 - 2030 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. SWOT Analysis
- 8.4.2. Asia Pacific Metagenomics market, 2018 - 2030 (USD Million)
- 8.4.3. Japan
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. Target Disease Prevalence
- 8.4.3.5. Japan Metagenomics market, 2018 - 2030 (USD Million)
- 8.4.4. China
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. Target Disease Prevalence
- 8.4.4.5. China Metagenomics market, 2018 - 2030 (USD Million)
- 8.4.5. India
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Target Disease Prevalence
- 8.4.5.5. India Metagenomics market, 2018 - 2030 (USD Million)
- 8.4.6. South Korea
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Target Disease Prevalence
- 8.4.6.5. South Korea Metagenomics market, 2018 - 2030 (USD Million)
- 8.4.7. Australia
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. Target Disease Prevalence
- 8.4.7.5. Australia Metagenomics market, 2018 - 2030 (USD Million)
- 8.4.8. Thailand
- 8.4.8.1. Key Country Dynamics
- 8.4.8.2. Competitive Scenario
- 8.4.8.3. Regulatory Framework
- 8.4.8.4. Target Disease Prevalence
- 8.4.8.5. Thailand Metagenomics market, 2018 - 2030 (USD Million)
- 8.5. Latin America
- 8.5.1. SWOT Analysis
- 8.5.2. Latin America Metagenomics market, 2018 - 2030 (USD Million)
- 8.5.3. Brazil
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Target Disease Prevalence
- 8.5.3.5. Brazil Metagenomics market, 2018 - 2030 (USD Million)
- 8.5.4. Mexico
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. Target Disease Prevalence
- 8.5.4.5. Mexico Metagenomics market, 2018 - 2030 (USD Million)
- 8.5.5. Argentina
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Competitive Scenario
- 8.5.5.3. Regulatory Framework
- 8.5.5.4. Target Disease Prevalence
- 8.5.5.5. Argentina Metagenomics market, 2018 - 2030 (USD Million)
- 8.6. MEA
- 8.6.1. SWOT Analysis
- 8.6.2. MEA Metagenomics market, 2018 - 2030 (USD Million)
- 8.6.3. South Africa
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Target Disease Prevalence
- 8.6.3.5. South Africa Metagenomics market, 2018 - 2030 (USD Million)
- 8.6.4. Saudi Arabia
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. Target Disease Prevalence
- 8.6.4.5. Saudi Arabia Metagenomics market, 2018 - 2030 (USD Million)
- 8.6.5. UAE
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Target Disease Prevalence
- 8.6.5.5. UAE Metagenomics market, 2018 - 2030 (USD Million)
- 8.6.6. Kuwait
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. Competitive Scenario
- 8.6.6.3. Regulatory Framework
- 8.6.6.4. Target Disease Prevalence
- 8.6.6.5. Kuwait Metagenomics market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Strategy Mapping
- 9.3. Company Profiles/Listing
- 9.3.1. Illumina, Inc.
- 9.3.1.1. Overview
- 9.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.1.3. Product Benchmarking
- 9.3.1.4. Strategic Initiatives
- 9.3.2. Thermo Fisher Scientific, Inc.
- 9.3.2.1. Overview
- 9.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.2.3. Product Benchmarking
- 9.3.2.4. Strategic Initiatives
- 9.3.3. Bio - Rad Laboratories, Inc..
- 9.3.3.1. Overview
- 9.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.3.3. Product Benchmarking
- 9.3.3.4. Strategic Initiatives
- 9.3.4. PerkinElmer, Inc.
- 9.3.4.1. Overview
- 9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.4.3. Product Benchmarking
- 9.3.4.4. Strategic Initiatives
- 9.3.5. Promega Corporation
- 9.3.5.1. Overview
- 9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.5.3. Product Benchmarking
- 9.3.5.4. Strategic Initiatives
- 9.3.6. Oxford Nanopore Technologies
- 9.3.6.1. Overview
- 9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.6.3. Product Benchmarking
- 9.3.6.4. Strategic Initiatives
- 9.3.7. Qiagen
- 9.3.7.1. Overview
- 9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.7.3. Product Benchmarking
- 9.3.7.4. Strategic Initiatives
- 9.3.8. Takara Bio, Inc.
- 9.3.8.1. Overview
- 9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.8.3. Product Benchmarking
- 9.3.8.4. Strategic Initiatives
- 9.3.9. Novogene Co., Ltd.
- 9.3.9.1. Overview
- 9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.9.3. Product Benchmarking
- 9.3.9.4. Strategic Initiatives
- 9.3.10. F. Hoffmann - La Roche Ltd.
- 9.3.10.1. Overview
- 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.10.3. Product Benchmarking
- 9.3.10.4. Strategic Initiatives
- 9.3.1. Illumina, Inc.
